drugset / Trial / NCT03364335

The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity

NCT03364335

Phase 2 Completed 267 enrolled NuSirt Biopharma
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a 24-week study to evaluate the effects of two fixed-dose combinations of leucine and sildenafil or two fixed-dose combinations of leucine, sildenafil and metformin compared to placebo. The primary objective of this study is to evaluate the percentage change in body weight in subjects from Baseline/Visit 2 (Day 1) to Study Termination/Visit 8 (Day 168/Week 24).

Timeline

Start
2018-01-08
Primary completion
2018-08-06
Completion
2018-08-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg
Subject Sildenafil Unknown 1 mg
Subject Sildenafil Unknown 4 mg
Subject amino acids Unknown 1100 mg

Indications